Key statistics dashboard for Nuwellis, Inc. (NUWE). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
Stock Data
| Price | $0.81 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.01 |
| Price / Book | -0.07 |
| P/S | 0.01 |
| P/FCF | -0.01 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 69.69% |
| EBIT Margin | -86.56% |
| EBITDA Margin | -81.66% |
| Operating Margin | -140.62% |
| Net Margin | -123.38% |
Financial Health
| Current Ratio | 1.97 |
| Quick Ratio | 1.54 |
| Cash Ratio | 0.98 |
| Debt / Equity | -0.10 |
| Debt / Assets | 2.19% |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -74.53 |
Per-Share Data
| Revenue per share | 49.73 |
| Book Value per share | -11.28 |
| Cash per share | 21.64 |
| FCF per share | -69.46 |
| Tangible Book Value per share | -11.85 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 0.50 |
Related companies: ACON · BACK · BCTXW · IVF · NUVO · OCEA · PETV
Explore sector: Healthcare · Medical - Devices
More sections of NUWE: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks